Bahaa Mustafa
Title | Assistant Professor |
---|
Institution | University of Arkansas for Medical Sciences |
---|
Department | COP | Pharmaceutical Science |
---|
Address | 4301 W Markham Little Rock AR 72205
|
---|
ORCID
| 0000-0002-3306-6140 |
---|
vCard | Download vCard |
---|
|
|
|
Overview Affiliation American Peptide Society American Association of Cancer Research
Biography Curriculum committee
Admission committee
University of Missouri-Kansas City, Kansas City | PhD | 05/2022 | Pharmaceutical Sciences | Petra University, Jordan | Masters | 07/2015 | Pharmaceutical Sciences | Applied Science University, Jordan | Bachelor | 01/2010 | Pharmacy |
2017 - 2021 | Fulbright Scholarship award, Department of state | 2022 | Best seminar speaker award, University of Missouri-Kansas City | 2022 | Preparing Future Faculty award, University of Missouri-Kansas City | 2018 - 2020 | Outstanding leadership award, University of Missouri-Kansas City |
Teaching Course instructor for Pharmaceutics I course
Course instructor for Pharmacology I course
Research A researcher with 5 years of cancer immunotherapy, biotherapeutics discovery, and nanomedicine experience. Successfully discovered peptide-based checkpoint inhibitors for cancer immunotherapy as well as established ELISA assay to screen innate immune checkpoint inhibitors. My strongest laboratory skills include molecular biology techniques, In-vivo studies, ELISA, cell-based assays, peptide phage display, SPR, and fluorescence microscopy.
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
Ferdous KU, Tesfay MZ, Cios A, Shelton RS, Hartupee C, Urbaniak A, Chamcheu JC, Mavros MN, Giorgakis E, Mustafa B, Simoes CC, Miousse IR, Basnakian AG, Moaven O, Post SR, Cannon MJ, Kelly T, Nagalo BM. Enhancing Neoadjuvant Virotherapy's Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer. Biomedicines. 2024 Jul 18; 12(7). PMID: 39062169.
-
Mustafa B, Fetse J, Kandel S, Lin CY, Adhikary P, Mamani UF, Liu Y, Ibrahim MN, Alahmari M, Cheng K. Discovery of Anti-CD47 Peptides as Innate Immune Checkpoint Inhibitors. Adv Ther (Weinh). 2023 Dec; 6(12). PMID: 38655206.
-
Fetse J, Zhao Z, Liu H, Mamani UF, Mustafa B, Adhikary P, Ibrahim M, Liu Y, Patel P, Nakhjiri M, Alahmari M, Li G, Cheng K. Discovery of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy. J Med Chem. 2022 09 22; 65(18):12002-12013. PMID: 36067356.
-
Liu H, Liu Y, Zhao Z, Li Y, Mustafa B, Chen Z, Barve A, Jain A, Yao X, Li G, Cheng K. Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy. Front Immunol. 2022; 13:838966. PMID: 35444660.
-
Adhikary P, Kandel S, Mamani UF, Mustafa B, Hao S, Qiu J, Fetse J, Liu Y, Ibrahim NM, Li Y, Lin CY, Omoscharka E, Cheng K. Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity. Adv Ther (Weinh). 2021 Jul; 4(7):2100087. PMID: 34179347.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2021 | 1 | 2022 | 2 | 2023 | 1 | 2024 | 1 |
To return to the timeline, click here.
|
Mustafa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|